Diagnostics
Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

Select Capabilities
Selected Work

Longitudinal Monitoring of Cancer Early Detection Market
Competitive Analysis

IVDR Opportunity Assessment
Voice-of-Customer Research

Infectious Pathogen Diagnostics Technology Commercialization
Voice-of-Customer Research






.png)
.png)



